✦ LIBER ✦

O3 Endobronchial photodynamic therapy with e6 chlorin in advanced stage of central lung cancer

✍ Scribed by A. Akopov; A. Rusanov; V. Molodtsova; G. Papayan; I. Chistiakov; N. Kazakov

Book ID: 119625285
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 40 KB
Volume: 7
Category: Article
ISSN: 1572-1000
DOI: 10.1016/s1572-1000(10)70018-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SPIE Proceedings [SPIE O-E/Fiber LASE '8

SPIE Proceedings [SPIE O-E/Fiber LASE '88 - Boston, MA (Tuesday 6 September 1988)] Advances in Photochemotherapy - Photodynamic Therapy Of Cancer

✍ Dougherty, Thomas J.; Hasan, Tayyaba 📂 Article 📅 1989 🏛 SPIE ⚖ 309 KB

Pharmacokinetics and clinical effects of

Pharmacokinetics and clinical effects of mono-l-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces

✍ Andrew L. Chan; Maya Juarez; Roblee Allen; William Volz; Timothy Albertson 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Development of the novel intervention th

Development of the novel intervention therapy for patients with advanced lung cancer in the central airways

✍ K. Ohtani; J. Usuda; S. Ichinose; T. Inoue; T. Ishizumi; M. Hoshi; H. Furumoto; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

The value of combined-modality therapy i

The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer

✍ Steven E. Schild; Sumithra J. Mandrekar; Aminah Jatoi; William L. McGinnis; Phil 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

## Abstract ## BACKGROUND. The objective of this study was to assess the value of combined‐modality therapy in elderly patients by comparing the differences in outcome between patients who received radiotherapy (RT) alone and patients who received RT plus chemotherapy for stage III nonsmall cell l

Randomized Multicenter Phase II Study of

Randomized Multicenter Phase II Study of Gemcitabine Versus Docetaxel as First-Line Therapy with Second-Line Crossover in Advanced-Stage Non–Small-Cell Lung Cancer

✍ Christian Manegold; Lothar Richard Pilz; Gabriele Koschel; Katrin Schott-von Röm 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 158 KB

O-88 Gemcitabine and cisplatin (GC) +/-s

O-88 Gemcitabine and cisplatin (GC) +/-subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG)

✍ Krzakowski, Maciel; Wenczl, Miklos; Brodowicz, Thomas; Tzekova, Valentina; Ramla 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB